{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T10:48:12Z","timestamp":1788691692194,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Rabies is known to be lethal in human. Treatment with passive immunity for the rabies is effective only when the patients have not shown the central nerve system (CNS) signs. The blood\u2013brain barrier (BBB) is a complex functional barrier that may compromise the therapeutic development in neurological diseases. The goal of this study is to determine the change of BBB integrity and to assess the therapeutic possibility of enhancing BBB permeability combined with passive immunity in the late stage of rabies virus infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The integrity of BBB permeability in rats was measured by quantitative ELISA for total IgG and albumin levels in the cerebrospinal fluid (CSF) and by exogenously applying Evans blue as a tracer. Western blotting of occludin and ZO-1, two tight junction proteins, was used to assess the molecular change of BBB structure.<\/jats:p>\n            <jats:p>The breakdown of BBB with hypertonic arabinose, recombinant tumor necrosis factor-alpha (rTNF-\u03b3), and focused ultrasound (FUS) were used to compare the extent of BBB disruption with rabies virus infection. Specific humoral immunity was analyzed by immunofluorescent assay and rapid fluorescent focus inhibition test. Virus-neutralizing monoclonal antibody (mAb) 8-10E was administered to rats with hypertonic breakdown of BBB as a passive immunotherapy to prevent the death from rabies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The BBB permeability was altered on day 7 post-infection. Increased BBB permeability induced by rabies virus infection was observed primarily in the cerebellum and spinal cord. Occludin was significantly decreased in both the cerebral cortex and cerebellum. The rabies virus-specific antibody was not strongly elicited even in the presence of clinical signs. Disruption of BBB had no direct association with the lethal outcome of rabies. Passive immunotherapy with virus-neutralizing mAb 8-10E with the hypertonic breakdown of BBB prolonged the survival of rabies virus-infected rats.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We demonstrated that the BBB permeability was altered in a rat model with rabies virus inoculation. Delivery of neutralizing mAb to the infected site in brain combined with effective breakdown of BBB could be an aggressive but feasible therapeutic mode in rabies when the CNS infection has been established.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1423-0127-19-61","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T14:26:47Z","timestamp":1340807207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Sufficient virus-neutralizing antibody in the central nerve system improves the survival of rabid rats"],"prefix":"10.1186","volume":"19","author":[{"given":"Pi-Hung","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Tse","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hseng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Chun","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Kuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,26]]},"reference":[{"key":"417_CR1","first-page":"1","volume":"931","author":"WHO","year":"2005","unstructured":"WHO: Expert Consultation on rabies. World Health Organ Tech Rep Ser. 2005, 931: 1-88. back cover","journal-title":"World Health Organ Tech Rep Ser"},{"key":"417_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.7705\/biomedica.v29i2.18","volume":"29","author":"AC Jackson","year":"2009","unstructured":"Jackson AC: Therapy of rabies encephalitis. Biomedica. 2009, 29: 169-176.","journal-title":"Biomedica"},{"key":"417_CR3","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1592\/phco.29.10.1182","volume":"29","author":"AJ Nigg","year":"2009","unstructured":"Nigg AJ, Walker PL: Overview, prevention, and treatment of rabies. Pharmacotherapy. 2009, 29: 1182-1195. 10.1592\/phco.29.10.1182.","journal-title":"Pharmacotherapy"},{"key":"417_CR4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1503\/cmaj.071326","volume":"178","author":"RC McDermid","year":"2008","unstructured":"McDermid RC, Saxinger L, Lee B, Johnstone J, Gibney RT, Johnson M, Bagshaw SM: Human rabies encephalitis following bat exposure: failure of therapeutic coma. CMAJ. 2008, 178: 557-561. 10.1503\/cmaj.071326.","journal-title":"CMAJ"},{"key":"417_CR5","first-page":"E070531","volume":"12","author":"S Schmiedel","year":"2007","unstructured":"Schmiedel S, Panning M, Lohse A, Kreymann KG, Gerloff C, Burchard G, Drosten C, Schmiedel S, Panning M, Lohse A, Kreymann KG, Gerloff C, Burchard G, Drosten C: Case report on fatal human rabies infection in Hamburg, Germany, March 2007. Euro Surveill. 2007, 12: E070531-E070535.","journal-title":"Euro Surveill"},{"key":"417_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/13550280600902295","volume":"12","author":"T Hemachudha","year":"2006","unstructured":"Hemachudha T, Sunsaneewitayakul B, Desudchit T, Suankratay C, Sittipunt C, Wacharapluesadee S, Khawplod P, Wilde H, Jackson AC: Failure of therapeutic coma and ketamine for therapy of human rabies. J Neurovirol. 2006, 12: 407-409. 10.1080\/13550280600902295.","journal-title":"J Neurovirol"},{"key":"417_CR7","first-page":"361","volume":"56","author":"Human rabies--Indiana and California","year":"2007","unstructured":"Human rabies--Indiana and California. MMWR Morb Mortal Wkly Rep. 2007, 56: 361-365.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"417_CR8","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1056\/NEJMoa050382","volume":"352","author":"RE Willoughby","year":"2005","unstructured":"Willoughby RE, Tieves KS, Hoffman GM, Ghanayem NS, Amlie-Lefond CM, Schwabe MJ, Chusid MJ, Rupprecht CE: Survival after treatment of rabies with induction of coma. N Engl J Med. 2005, 352: 2508-2514. 10.1056\/NEJMoa050382.","journal-title":"N Engl J Med"},{"key":"417_CR9","doi-asserted-by":"publisher","first-page":"7993","DOI":"10.1128\/JVI.00710-07","volume":"81","author":"A Roy","year":"2007","unstructured":"Roy A, Hooper DC: Lethal silver-haired bat rabies virus infection can be prevented by opening the blood\u2013brain barrier. J Virol. 2007, 81: 7993-7998. 10.1128\/JVI.00710-07.","journal-title":"J Virol"},{"key":"417_CR10","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1128\/JVI.01964-06","volume":"81","author":"A Roy","year":"2007","unstructured":"Roy A, Phares TW, Koprowski H, Hooper DC: Failure to open the blood\u2013brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection. J Virol. 2007, 81: 1110-1118. 10.1128\/JVI.01964-06.","journal-title":"J Virol"},{"key":"417_CR11","first-page":"828","volume":"51","author":"Human rabies--Tennessee","year":"2002","unstructured":"Human rabies--Tennessee. MMWR Morb Mortal Wkly Rep. 2002, 51: 828-829.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"417_CR12","first-page":"460","volume":"57","author":"Human rabies--Minnesota","year":"2008","unstructured":"Human rabies--Minnesota. MMWR Morb Mortal Wkly Rep. 2008, 57: 460-462.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"417_CR13","first-page":"121","volume":"13","author":"O Despond","year":"2002","unstructured":"Despond O, Tucci M, Decaluwe H, Gregoire MC, S Teitelbaum J, Turgeon N: Rabies in a nine-year-old child: The myth of the bite. Can J Infect Dis. 2002, 13: 121-125.","journal-title":"Can J Infect Dis"},{"key":"417_CR14","first-page":"1102","volume":"24","author":"J Laothamatas","year":"2003","unstructured":"Laothamatas J, Hemachudha T, Mitrabhakdi E, Wannakrairot P, Tulayadaechanont S: MR imaging in human rabies. Am J Neuroradiol. 2003, 24: 1102-1109.","journal-title":"Am J Neuroradiol"},{"key":"417_CR15","first-page":"677","volume":"22","author":"M Awasthi","year":"2001","unstructured":"Awasthi M, Parmar H, Patankar T, Castillo M: Imaging findings in rabies encephalitis. Am J Neuroradiol. 2001, 22: 677-680.","journal-title":"Am J Neuroradiol"},{"key":"417_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0165-0270(95)00080-1","volume":"63","author":"YL Huang","year":"1995","unstructured":"Huang YL, Saljo A, Suneson A, Hansson HA: A new approach for multiple sampling of cisternal cerebrospinal fluid in rodents with minimal trauma and inflammation. J Neurosci Methods. 1995, 63: 13-22. 10.1016\/0165-0270(95)00080-1.","journal-title":"J Neurosci Methods"},{"key":"417_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0165-0270(02)00033-X","volume":"116","author":"MP van den Berg","year":"2002","unstructured":"van den Berg MP, Romeijn SG, Verhoef JC, Merkus FW: Serial cerebrospinal fluid sampling in a rat model to study drug uptake from the nasal cavity. J Neurosci Methods. 2002, 116: 99-107. 10.1016\/S0165-0270(02)00033-X.","journal-title":"J Neurosci Methods"},{"key":"417_CR18","doi-asserted-by":"publisher","first-page":"R18","DOI":"10.1186\/cc3004","volume":"9","author":"F Esen","year":"2005","unstructured":"Esen F, Erdem T, Aktan D, Orhan M, Kaya M, Eraksoy H, Cakar N, Telci L: Effect of magnesium sulfate administration on blood\u2013brain barrier in a rat model of intraperitoneal sepsis: a randomized controlled experimental study. Crit Care. 2005, 9: R18-R23. 10.1186\/cc3004.","journal-title":"Crit Care"},{"key":"417_CR19","first-page":"R421","volume":"238","author":"SI Rapoport","year":"1980","unstructured":"Rapoport SI, Fredericks WR, Ohno K, Pettigrew KD: Quantitative aspects of reversible osmotic opening of the blood\u2013brain barrier. Am J Physiol. 1980, 238: R421-R431.","journal-title":"Am J Physiol"},{"key":"417_CR20","first-page":"R459","volume":"253","author":"PJ Robinson","year":"1987","unstructured":"Robinson PJ, Rapoport SI: Size selectivity of blood\u2013brain barrier permeability at various times after osmotic opening. Am J Physiol. 1987, 253: R459-R466.","journal-title":"Am J Physiol"},{"key":"417_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1023\/A:1007049806660","volume":"20","author":"SI Rapoport","year":"2000","unstructured":"Rapoport SI: Osmotic opening of the blood\u2013brain barrier: principles, mechanism, and therapeutic applications. Cell Mol Neurobiol. 2000, 20: 217-230. 10.1023\/A:1007049806660.","journal-title":"Cell Mol Neurobiol"},{"key":"417_CR22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/jcbfm.2009.251","volume":"30","author":"HL Liu","year":"2010","unstructured":"Liu HL, Wai YY, Hsu PH, Lyu LA, Wu JS, Shen CR, Chen JC, Yen TC, Wang JJ: In vivo assessment of macrophage CNS infiltration during disruption of the blood\u2013brain barrier with focused ultrasound: a magnetic resonance imaging study. J Cerebral Blood Flow Metab. 2010, 30: 674-10.1038\/jcbfm.2009.251.","journal-title":"J Cerebral Blood Flow Metab"},{"key":"417_CR23","doi-asserted-by":"publisher","first-page":"15205","DOI":"10.1073\/pnas.1003388107","volume":"107","author":"HL Liu","year":"2010","unstructured":"Liu HL, Hua MY, Yang HW, Huang CY, Chu PC, Wu JS, Tseng IC, Wang JJ, Yen TC, Chen PY, Wei KC: Magnetic resonance monitoring of focused ultrasound\/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc Natl Acad Sci U S A. 2010, 107: 15205-15210. 10.1073\/pnas.1003388107.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"417_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0092-1157(79)80024-4","volume":"7","author":"E Zalan","year":"1979","unstructured":"Zalan E, Wilson C, Pukitis D: A microtest for the quantitation of rabies virus neutralizing antibodies. J Biol Stand. 1979, 7: 213-220. 10.1016\/S0092-1157(79)80024-4.","journal-title":"J Biol Stand"},{"key":"417_CR25","first-page":"535","volume":"48","author":"JS Smith","year":"1973","unstructured":"Smith JS, Yager PA, Baer GM: A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ. 1973, 48: 535-541.","journal-title":"Bull World Health Organ"},{"key":"417_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1124\/pr.57.2.4","volume":"57","author":"BT Hawkins","year":"2005","unstructured":"Hawkins BT, Davis TP: The blood\u2013brain barrier\/neurovascular unit in health and disease. Pharmacol Rev. 2005, 57: 173-185. 10.1124\/pr.57.2.4.","journal-title":"Pharmacol Rev"},{"key":"417_CR27","doi-asserted-by":"publisher","first-page":"7666","DOI":"10.4049\/jimmunol.176.12.7666","volume":"176","author":"TW Phares","year":"2006","unstructured":"Phares TW, Kean RB, Mikheeva T, Hooper DC: Regional differences in blood\u2013brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J Immunol. 2006, 176: 7666-7675.","journal-title":"J Immunol"},{"key":"417_CR28","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0002-9440(10)65511-3","volume":"155","author":"LM Dallasta","year":"1999","unstructured":"Dallasta LM, Pisarov LA, Esplen JE, Werley JV, Moses AV, Nelson JA, Achim CL: Blood\u2013brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathoy. 1999, 155: 1915-1927. 10.1016\/S0002-9440(10)65511-3.","journal-title":"Am J Pathoy"},{"issue":"Suppl 5","key":"417_CR29","first-page":"S63","volume":"32","author":"I Ng","year":"2003","unstructured":"Ng I, Yap E, Tan WL, Kong NY: Blood\u2013brain barrier disruption following traumatic brain injury: roles of tight junction proteins. Ann Acad Med Singapore. 2003, 32 (Suppl 5): S63-S66.","journal-title":"Ann Acad Med Singapore"},{"key":"417_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/path.1434","volume":"201","author":"J Kirk","year":"2003","unstructured":"Kirk J, Plumb J, Mirakhur M, McQuaid S: Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood\u2013brain barrier leakage and active demyelination. J Pathog. 2003, 201: 319-327.","journal-title":"J Pathog"},{"key":"417_CR31","doi-asserted-by":"publisher","first-page":"H1485","DOI":"10.1152\/ajpheart.00645.2001","volume":"282","author":"KS Mark","year":"2002","unstructured":"Mark KS, Davis TP: Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol. 2002, 282: H1485-H1494.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"417_CR32","doi-asserted-by":"publisher","first-page":"H738","DOI":"10.1152\/ajpheart.01288.2004","volume":"289","author":"TA Brooks","year":"2005","unstructured":"Brooks TA, Hawkins BT, Huber JD, Egleton RD, Davis TP: Chronic inflammatory pain leads to increased blood\u2013brain barrier permeability and tight junction protein alterations. Am J Physiol Heart Circ Physiol. 2005, 289: H738-H743. 10.1152\/ajpheart.01288.2004.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"417_CR33","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.neulet.2010.07.035","volume":"482","author":"T Nishioku","year":"2010","unstructured":"Nishioku T, Yamauchi A, Takata F, Watanabe T, Furusho K, Shuto H, Dohgu S, Kataoka Y: Disruption of the blood\u2013brain barrier in collagen-induced arthritic mice. Neurosci Lett. 2010, 482: 208-211. 10.1016\/j.neulet.2010.07.035.","journal-title":"Neurosci Lett"},{"key":"417_CR34","doi-asserted-by":"crossref","first-page":"G851","DOI":"10.1152\/ajpgi.2000.279.5.G851","volume":"279","author":"A Nusrat","year":"2000","unstructured":"Nusrat A, Turner JR, Madara JL: Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol. 2000, 279: G851-G857.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"417_CR35","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0166-2236(00)02004-X","volume":"24","author":"JD Huber","year":"2001","unstructured":"Huber JD, Egleton RD, Davis TP: Molecular physiology and pathophysiology of tight junctions in the blood\u2013brain barrier. Trends Neurosci. 2001, 24: 719-725. 10.1016\/S0166-2236(00)02004-X.","journal-title":"Trends Neurosci"},{"key":"417_CR36","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/978-1-60761-938-3_23","volume":"686","author":"M Blanchette","year":"2011","unstructured":"Blanchette M, Fortin D: Blood\u2013brain barrier disruption in the treatment of brain tumors. Methods Mol Biol. 2011, 686: 447-463. 10.1007\/978-1-60761-938-3_23.","journal-title":"Methods Mol Biol"},{"key":"417_CR37","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1517\/13543784.10.10.1809","volume":"10","author":"SI Rapoport","year":"2001","unstructured":"Rapoport SI: Advances in osmotic opening of the blood\u2013brain barrier to enhance CNS chemotherapy. Expert opin investigat drugs. 2001, 10: 1809-1818. 10.1517\/13543784.10.10.1809.","journal-title":"Expert opin investigat drugs"},{"key":"417_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF02594584","volume":"5","author":"V Rousseau","year":"1997","unstructured":"Rousseau V, Denizot B, Pouliquen D, Jallet P, Le Jeune JJ: Investigation of blood\u2013brain barrier permeability to magnetite-dextran nanoparticles (MD3) after osmotic disruption in rats. MAGMA. 1997, 5: 213-222. 10.1007\/BF02594584.","journal-title":"MAGMA"},{"key":"417_CR39","doi-asserted-by":"publisher","first-page":"9829","DOI":"10.1073\/pnas.92.21.9829","volume":"92","author":"G Nilaver","year":"1995","unstructured":"Nilaver G, Muldoon LL, Kroll RA, Pagel MA, Breakefield XO, Davidson BL, Neuwelt EA: Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood\u2013brain barrier disruption. Proc Natl Acad Sci U S A. 1995, 92: 9829-9833. 10.1073\/pnas.92.21.9829.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"417_CR40","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/0014-4886(76)90154-0","volume":"53","author":"JT Hicks","year":"1976","unstructured":"Hicks JT, Albrecht P, Rapoport SI: Entry of neutralizing antibody to measles into brain and cerebrospinal fluid of immunized monkeys after osmotic opening of the blood\u2013brain barrier. Exp Neurol. 1976, 53: 768-779. 10.1016\/0014-4886(76)90154-0.","journal-title":"Exp Neurol"},{"key":"417_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0304-3940(96)12546-5","volume":"208","author":"CS Abraham","year":"1996","unstructured":"Abraham CS, Deli MA, Joo F, Megyeri P, Torpier G: Intracarotid tumor necrosis factor-alpha administration increases the blood\u2013brain barrier permeability in cerebral cortex of the newborn pig: quantitative aspects of double-labelling studies and confocal laser scanning analysis. Neurosci Lett. 1996, 208: 85-88. 10.1016\/0304-3940(96)12546-5.","journal-title":"Neurosci Lett"},{"key":"417_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF01057957","volume":"20","author":"JL Wright","year":"1994","unstructured":"Wright JL, Merchant RE: Blood\u2013brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-alpha in the rat. J Neuro-oncol. 1994, 20: 17-25. 10.1007\/BF01057957.","journal-title":"J Neuro-oncol"},{"key":"417_CR43","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.bbrc.2005.12.112","volume":"340","author":"M Kinoshita","year":"2006","unstructured":"Kinoshita M, McDannold N, Jolesz FA, Hynynen K: Targeted delivery of antibodies through the blood\u2013brain barrier by MRI-guided focused ultrasound. Bioche Biophys Res Comm. 2006, 340: 1085-1090. 10.1016\/j.bbrc.2005.12.112.","journal-title":"Bioche Biophys Res Comm"},{"key":"417_CR44","doi-asserted-by":"publisher","first-page":"11719","DOI":"10.1073\/pnas.0604318103","volume":"103","author":"M Kinoshita","year":"2006","unstructured":"Kinoshita M, McDannold N, Jolesz FA, Hynynen K: Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood\u2013brain barrier disruption. Proc Natl Acad Sci U S A. 2006, 103: 11719-11723. 10.1073\/pnas.0604318103.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"417_CR45","first-page":"207","volume":"55","author":"Human rabies--Mississippi, 2005","year":"2006","unstructured":"Human rabies--Mississippi, 2005. MMWR Morb Mortal Wkly Rep. 2006, 55: 207-208.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"417_CR46","first-page":"4725","volume":"48","author":"EA Neuwelt","year":"1988","unstructured":"Neuwelt EA, Barnett PA, Hellstrom I, Hellstrom KE, Beaumier P, McCormick CI, Weigel RM: Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood\u2013brain barrier disruption. Cancer Res. 1988, 48: 4725-4729.","journal-title":"Cancer Res"},{"key":"417_CR47","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3171\/2010.9.JNS101223","volume":"114","author":"JA Boockvar","year":"2011","unstructured":"Boockvar JA, Tsiouris AJ, Hofstetter CP, Kovanlikaya I, Fralin S, Kesavabhotla K, Seedial SM, Pannullo SC, Schwartz TH, Stieg P, Zimmerman RD, Knopman J, Scheff RJ, Christos P, Vallabhajosula S, Riina HA: Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood\u2013brain barrier disruption for recurrent malignant glioma. Clinical article. J Neurosurg. 2011, 114: 624-632.","journal-title":"Clinical article. J Neurosurg"},{"key":"417_CR48","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1208\/s12248-008-9018-7","volume":"10","author":"MA Bellavance","year":"2008","unstructured":"Bellavance MA, Blanchette M, Fortin D: Recent advances in blood\u2013brain barrier disruption as a CNS delivery strategy. AAPS J. 2008, 10: 166-177. 10.1208\/s12248-008-9018-7.","journal-title":"AAPS J"},{"key":"417_CR49","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1017\/S0317167100012075","volume":"38","author":"AC Jackson","year":"2011","unstructured":"Jackson AC: Rabies in the critical care unit: diagnostic and therapeutic approaches. Can J Neurol Sci. 2011, 38: 689-695.","journal-title":"Can J Neurol Sci"},{"key":"417_CR50","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/jmv.21785","volume":"82","author":"M Hunter","year":"2010","unstructured":"Hunter M, Johnson N, Hedderwick S, McCaughey C, Lowry K, McConville J, Herron B, McQuaid S, Marston D, Goddard T, Harkess G, Goharriz H, Voller K, Solomon T, Willoughby RE, Fooks AR: Immunovirological correlates in human rabies treated with therapeutic coma. J Med Virol. 2010, 82: 1255-1265. 10.1002\/jmv.21785.","journal-title":"J Med Virol"},{"key":"417_CR51","doi-asserted-by":"publisher","first-page":"191","DOI":"10.7705\/biomedica.v29i2.21","volume":"29","author":"R Badillo","year":"2009","unstructured":"Badillo R, Mantilla JC, Pradilla G: Human rabies encephalitis by a vampire bat bite in an urban area of Colombia. Biomedica. 2009, 29: 191-203.","journal-title":"Biomedica"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1423-0127-19-61.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:37:01Z","timestamp":1630525021000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/1423-0127-19-61"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,26]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["417"],"URL":"https:\/\/doi.org\/10.1186\/1423-0127-19-61","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,26]]},"assertion":[{"value":"9 April 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"61"}}